- Oops!Something went wrong.Please try again later.
The Alliance Pharma (LON:APH) share price has risen by 1.23% over the past month and it’s currently trading at 115.4p. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.
According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Alliance Pharma currently has:
3 Buy recommendations
0 Hold recommendations
0 Sell recommendations
This suggests that analysts are generally positive about the outlook.
Going beyond analyst recommendations
At its current price of 115.4p, shares in Alliance Pharma are trading at a discount of -6.18% to its 52 week high price. The 1-year performance of the shares has been 17.3%.
While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Alliance Pharma it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Alliance Pharma that you can find out about here.